What is Boca Biolistics?
Boca Biolistics specializes in providing comprehensive biospecimen procurement, clinical research services, and central laboratory testing. The company sources a wide array of biospecimens, including biofluids and tissues, from an extensive global network spanning over 120 collection sites across 50 countries. Its services are crucial for clients within the IVD and pharmaceutical industries, supporting critical research in oncology, infectious diseases, and autoimmune conditions. Boca Biolistics is dedicated to fostering innovation and enabling life-changing discoveries through robust partnerships.
How much funding has Boca Biolistics raised?
Boca Biolistics has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Boca Biolistics
PPP
Public-Private Partnership
What's next for Boca Biolistics?
With substantial backing, Boca Biolistics is poised for continued growth and expansion in its specialized areas of biospecimen management and clinical research support. The company's strategic focus on advancing healthcare and scientific research, particularly in complex disease areas, suggests future investments will likely target the enhancement of its global sourcing capabilities and the expansion of its central laboratory testing infrastructure. This capital infusion is expected to solidify its role as a key partner for pharmaceutical and IVD companies driving medical innovation.
See full Boca Biolistics company page
